tiprankstipranks
Aim Immunotech Inc. (AIM)
XASE:AIM
US Market
AIM
AIM ImmunoTech
RESEARCH TOOLSreports
Want to see AIM full AI Analyst Report?

AIM ImmunoTech (AIM) Ratios

971 Followers

AIM ImmunoTech Ratios

AIM's free cash flow for Q4 2025 was $-2.95. For the 2025 fiscal year, AIM's free cash flow was decreased by $ and operating cash flow was $-119.57. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Dec 24Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.53 0.53 0.44 1.68 26.69
Quick Ratio
 0.53 0.53 0.44 1.72 26.69
Cash Ratio
 0.15 0.15 0.18 0.63 19.88
Solvency Ratio
 -0.88 -0.88 -1.72 -3.14 -9.84
Operating Cash Flow Ratio
 -1.76 -1.76 -1.56 -2.46 -11.84
Short-Term Operating Cash Flow Coverage
 -2.88 -2.88 -6.45 0.00 0.00
Net Current Asset Value
$ -12.27M$ -12.27M$ -5.75M$ 5.41M$ 34.30M
Leverage Ratios
Debt-to-Assets Ratio
 0.85 0.85 0.34 0.04 0.02
Debt-to-Equity Ratio
 -0.50 -0.50 -2.22 0.07 0.02
Debt-to-Capital Ratio
 -1.00 -1.00 1.82 0.07 0.02
Long-Term Debt-to-Capital Ratio
 -0.10 -0.10 0.00 0.00 0.00
Financial Leverage Ratio
 -0.59 -0.59 -6.51 1.89 1.05
Debt Service Coverage Ratio
 -2.52 -2.24 -5.70 0.00 0.00
Interest Coverage Ratio
 -13.72 -12.96 -33.80 0.00 0.00
Debt to Market Cap
 2.71 2.58 0.08 0.00 0.00
Interest Debt Per Share
 1.86 3.53 2.28 1.48 1.74
Net Debt to EBITDA
 -0.34 -0.38 -0.08 0.16 1.32
Profitability Margins
Gross Profit Margin
-155.68%-284.09%81.76%79.21%400.71%
EBIT Margin
-13492.05%-11961.36%-9844.12%-14337.62%-13790.78%
EBITDA Margin
-13180.68%-11722.73%-9699.41%-14219.80%-14091.49%
Operating Profit Margin
-12660.23%-11961.36%-11630.59%-15800.00%-14129.65%
Pretax Profit Margin
-15861.36%-15861.36%-10188.24%-14337.62%-13790.78%
Net Profit Margin
-15861.36%-15861.36%-10188.24%-14337.62%-13790.78%
Continuous Operations Profit Margin
-15861.36%-15861.36%-10188.24%-14337.62%-13790.78%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
125.28%132.60%87.60%90.74%97.60%
Return on Assets (ROA)
-241.40%-241.40%-201.21%-149.44%-48.03%
Return on Equity (ROE)
212.59%142.68%1310.14%-283.00%-50.55%
Return on Capital Employed (ROCE)
2520.59%2381.45%2132.90%-297.47%-50.92%
Return on Invested Capital (ROIC)
-331.87%-313.55%-1221.25%-291.42%-50.69%
Return on Tangible Assets
-338.70%-338.70%-287.99%-169.69%-50.44%
Earnings Yield
-863.54%-763.13%-59.59%-135.48%-130.55%
Efficiency Ratios
Receivables Turnover
 12.57 12.57 0.00 0.17 0.08
Payables Turnover
 0.14 0.21 <0.01 <0.01 -1.12
Inventory Turnover
 0.00 0.00 0.00 -0.14 0.00
Fixed Asset Turnover
 0.00 0.00 0.23 0.25 0.14
Asset Turnover
 0.02 0.02 0.02 0.01 <0.01
Working Capital Turnover Ratio
 -0.04 -0.02 0.62 <0.01 <0.01
Cash Conversion Cycle
 -2.62K -1.73K -75.15K -56.48K 4.66K
Days of Sales Outstanding
 29.03 29.03 0.00 2.14K 4.34K
Days of Inventory Outstanding
 0.00 0.00 0.00 -2.62K 0.00
Days of Payables Outstanding
 2.64K 1.76K 75.15K 55.99K -324.54
Operating Cycle
 29.03 29.03 0.00 -485.12 4.34K
Cash Flow Ratios
Operating Cash Flow Per Share
 -3.57 -6.77 -9.64 -43.77 -33.53
Free Cash Flow Per Share
 -3.66 -6.77 -9.65 -44.98 -34.09
CapEx Per Share
 0.09 0.00 0.01 1.20 0.56
Free Cash Flow to Operating Cash Flow
 1.03 1.00 1.00 1.03 1.02
Dividend Paid and CapEx Coverage Ratio
 -38.72 0.00 -827.11 -36.35 -59.44
Capital Expenditure Coverage Ratio
 -38.72 0.00 -827.11 -36.35 -59.44
Operating Cash Flow Coverage Ratio
 -2.24 -2.24 -5.06 -29.62 -19.24
Operating Cash Flow to Sales Ratio
 -124.51 -124.51 -87.58 -105.28 -114.24
Free Cash Flow Yield
-627.84%-599.06%-51.28%-102.22%-109.97%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.11 -0.13 -1.68 -0.74 -0.77
Price-to-Sales (P/S) Ratio
 19.79 20.78 170.97 105.83 105.64
Price-to-Book (P/B) Ratio
 -0.16 -0.19 -21.99 2.09 0.39
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.15 -0.17 -1.95 -0.98 -0.91
Price-to-Operating Cash Flow Ratio
 -0.14 -0.17 -1.95 -1.01 -0.92
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 0.03 -0.02 -4.42
Price-to-Fair Value
 -0.16 -0.19 -21.99 2.09 0.39
Enterprise Value Multiple
 -0.49 -0.56 -1.84 -0.58 0.57
Enterprise Value
 5.76M 5.79M 30.31M 16.66M -11.32M
EV to EBITDA
 -0.50 -0.56 -1.84 -0.58 0.57
EV to Sales
 65.40 65.84 178.27 82.46 -80.29
EV to Free Cash Flow
 -0.51 -0.53 -2.03 -0.76 0.69
EV to Operating Cash Flow
 -0.53 -0.53 -2.04 -0.78 0.70
Tangible Book Value Per Share
 -3.72 -7.07 -2.54 16.30 76.02
Shareholders’ Equity Per Share
 -3.18 -6.04 -0.86 21.06 80.06
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.03 0.05 0.11 0.42 0.29
Net Income Per Share
 -4.54 -8.62 -11.21 -59.61 -40.47
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.18 1.33 1.03 1.00 1.00
Research & Development to Revenue
 39.58 44.59 36.45 54.08 49.57
SG&A to Revenue
 87.01 87.50 80.67 104.64 92.72
Stock-Based Compensation to Revenue
 0.68 0.68 4.04 1.20 6.77
Income Quality
 0.78 0.78 0.86 0.73 0.83
Currency in USD